Dual Blockade of CD44v6 and PI3K Undermines Colorectal Cancer Stem Cell Reprogramming
A preclinical study reports that combining the CD44v6 inhibitor AMC303 with the dual PI3K/mTOR inhibitor Apitolisib suppresses HGF-driven reprogramming and ...
Tag: Apitolisib
POPULAR NEWS
-
Two Isocyanurate Resins, One Lesson: Strongest Binding Is Not Best Column Performance
-
Dual Blockade of CD44v6 and PI3K Undermines Colorectal Cancer Stem Cell Reprogramming
-
Chromium Additive Boosts Sensitivity of 1,1-ADEQUATE NMR Fourfold
-
CRISPR promoter editing trims rice stomata to boost water efficiency with a yield trade-off